Sign in
4

Changes in Ownership

BIOMARIN PHARMACEUTICAL INC Filed Acc 0001048477-24-000002

Director sold 20,000 shares at an average $97.29 ($1,945,700)

  • Director acquired 20,000 shares (option exercise)
  • Director acquired 50 shares (code L)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
BIENAIME JEAN JACQUES Director 2024-01-08 Other acquisition 10b5-1 +50 $99.05 $4,953 425,162 D: show line 1 in the form
BIENAIME JEAN JACQUES Director 2024-01-09 Option exercise 10b5-1 +10,000 $63.10 $631,000 435,162 D: show line 2 in the form
BIENAIME JEAN JACQUES Director 2024-01-09 Sale 10b5-1 −10,000 $98.19 $981,900 425,162 D: show line 3 in the form
BIENAIME JEAN JACQUES Director 2024-01-10 Option exercise 10b5-1 +10,000 $63.10 $631,000 435,162 D: show line 4 in the form
BIENAIME JEAN JACQUES Director 2024-01-10 Sale 10b5-1 −10,000 $96.38 $963,800 425,162 D: show line 5 in the form
Open-market sales · 20,000 sh · avg $97.29 · $1,945,700

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
BIENAIME JEAN JACQUES Director 2024-01-09 Option exercise · Stock Option (Right to Buy Common Stock) 10b5-1 −10,000 171,000 D: show line 6 in the form
BIENAIME JEAN JACQUES Director 2024-01-10 Option exercise · Stock Option (Right to Buy Common Stock) 10b5-1 −10,000 161,000 D: show line 7 in the form
Loading xslF345X05/wk-form4_1705002030.xml…